imipenem, anhydrous has been researched along with Kidney Diseases in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (28.57) | 18.7374 |
| 1990's | 7 (33.33) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, X; Liu, K; Ma, X; Meng, Q; Sun, H; Sun, P; Wang, C; Wu, J; Zhu, Y | 1 |
| Ababneh, MA; Al Demour, S; Alzoubi, KH; Hijjawi, TB; Rababa’h, AM | 1 |
| Bae, CS; Han, HK; Han, SI; Im, YB; Kim, SE; Lim, SC | 1 |
| Ha, JR; Kim, BO; Kim, HG; Kim, JG; Kim, JM; Lee, DG; Lee, JM; Lee, SH; Oh, SW | 1 |
| Asner, S; Buclin, T; Calandra, T; Erard, V; Lamoth, F; Marchetti, O | 1 |
| Hayashi, T; Imanishi, M; Kadowaki, T; Kurita, T; Sugimoto, K | 1 |
| Al-Ebous, AD; Al-Jahmi, M; Al-Zuriqat, AN; Hiasat, B; Sarayrah, M | 1 |
| Birnbaum, J; Kahan, FM; Kropp, H; Sundelof, JG | 1 |
| Fernández-del Castillo, C; Ferraro, MJ; Foitzik, T; Mithöfer, K; Rattner, DW; Warshaw, AL | 1 |
| Claude, JR; Debray, M; Dutertre-Catella, H; Martin, C; Pham-Huy, C; Podevin, RA; Thevenin, M; Warnet, JM | 1 |
| Hirouchi, Y; Hori, R; Inui, K; Kamiya, A; Kawahara, Y; Naganuma, H; Okada, R | 1 |
| Koch, FW; Kohl, FV; Küchler, R; Pankow, W; Zöller, M | 1 |
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Jacolot, A; Leotard, S; Louchahi, K; Mimoz, O; Nordmann, P; Padoin, C; Petitjean, O | 1 |
| Bland, JA; Graziani, AL; Lawson, LA; MacGregor, RR; Pietroski, NA; Rogers, JD | 1 |
| Abel, SR; Guba, EA | 1 |
| Kodama, H; Konishi, Y; Kumon, H; Nasu, Y; Ohmori, H | 1 |
| Drusano, GL | 1 |
| Bland, JA; Demetriades, JL; Gibson, TP | 1 |
| Alpert, G; Bloh, AM; Campos, JM; Connor, E; Dagan, R; Plotkin, SA; Powell, KR | 1 |
4 review(s) available for imipenem, anhydrous and Kidney Diseases
| Article | Year |
|---|---|
[A case of inflammatory pseudotumor of renal pelvis showing a complete response to antibiotics].
Topics: Adult; Anti-Bacterial Agents; Female; Granuloma, Plasma Cell; Humans; Imipenem; Kidney; Kidney Diseases; Kidney Pelvis; Radiography, Abdominal; Remission Induction; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Thienamycin: development of imipenen-cilastatin.
Topics: Animals; Bacteria; beta-Lactamases; Chemical Phenomena; Chemistry; Cilastatin; Cyclopropanes; Dipeptidases; Drug Resistance, Microbial; Humans; Imipenem; Kidney Diseases; Thienamycins | 1983 |
[An acute septic course of melioidosis after a stay in Thailand].
Topics: Abscess; Acute Disease; Aged; Combined Modality Therapy; Diabetes Mellitus, Type 2; Fatal Outcome; Humans; Imipenem; Kidney Diseases; Male; Melioidosis; Nephrectomy; Thailand; Thienamycins; Travel | 1997 |
An overview of the pharmacology of imipenem/cilastatin.
Topics: Cilastatin; Cyclopropanes; Dipeptidases; Humans; Imipenem; Kidney; Kidney Diseases; Kinetics; Thienamycins | 1986 |
1 trial(s) available for imipenem, anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Management of diabetic foot in a Jordanian hospital.
Topics: Amikacin; Amputation, Surgical; Anti-Bacterial Agents; Ceftazidime; Chemotherapy, Adjuvant; Debridement; Diabetic Foot; Drug Combinations; Drug Monitoring; Humans; Imipenem; Kidney Diseases; Length of Stay; Lincomycin; Metronidazole; Patient Selection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Severity of Illness Index; Treatment Outcome; Wound Healing; Wound Infection | 2005 |
16 other study(ies) available for imipenem, anhydrous and Kidney Diseases
| Article | Year |
|---|---|
Targeting renal OATs to develop renal protective agent from traditional Chinese medicines: Protective effect of Apigenin against Imipenem-induced nephrotoxicity.
Topics: Animals; Apigenin; Humans; Imipenem; Kidney Diseases; Kidney Tubules, Proximal; Male; Medicine, Chinese Traditional; Organic Anion Transporters; Rabbits; Transfection | 2020 |
The Nephroprotective Effect of N-Acetyl-L-Cysteine and Atorvastatin against Imipenem induced Nephrotoxicity.
Topics: Acetylcysteine; Animals; Antioxidants; Atorvastatin; Blood Urea Nitrogen; Creatinine; Glomerular Filtration Rate; Glycosuria; Imipenem; Kidney; Kidney Diseases; Male; Protective Agents; Proteinuria; Rats, Sprague-Dawley; Thiobarbituric Acid Reactive Substances; Urea | 2018 |
Protective effect of morin on the imipenem-induced nephrotoxicity in rabbits.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Cell Line; Dogs; Flavonoids; Imipenem; Kidney; Kidney Diseases; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Rabbits; Transfection | 2008 |
Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Imipenem; Kidney; Kidney Diseases; Male; Meropenem; Pyrrolidines; Rabbits; Thienamycins | 2008 |
High imipenem blood concentrations associated with toxic encephalopathy in a patient with mild renal dysfunction.
Topics: Aged; Anti-Bacterial Agents; Catheter-Related Infections; Enterocolitis; Fatal Outcome; Female; Humans; Imipenem; Kidney Diseases; Neurotoxicity Syndromes; Sepsis; Staphylococcal Infections; Staphylococcus haemolyticus; Vancomycin | 2009 |
Pathogenesis and prevention of early pancreatic infection in experimental acute necrotizing pancreatitis.
Topics: Acute Disease; Administration, Oral; Amphotericin B; Animals; Bacteria; Bacterial Infections; Bacterial Physiological Phenomena; Cecal Diseases; Cefotaxime; Colistin; Disease Models, Animal; Drug Therapy, Combination; Imipenem; Injections, Intravenous; Kidney Diseases; Male; Necrosis; Pancreas; Pancreatic Diseases; Pancreatitis; Rats; Rats, Sprague-Dawley; Survival Rate; Tobramycin | 1995 |
Rabbit renal proximal tubule suspensions as a model for nephrotoxicity evaluation of native or in situ metabolized beta-lactam antibiotics.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Cephaloridine; Cilastatin; Energy Metabolism; Female; Glutathione; Imipenem; In Vitro Techniques; Kidney Diseases; Kidney Tubules, Proximal; Rabbits | 1995 |
Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.
Topics: Alanine; Animals; Carbapenems; Glycosuria, Renal; Imipenem; In Vitro Techniques; Kidney Cortex; Kidney Diseases; Male; Necrosis; Proteinuria; Rabbits; Thienamycins | 1994 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |
Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; beta-Lactamases; Carbapenems; Cefepime; Ceftazidime; Cephalosporins; Creatinine; Drug Resistance, Microbial; Enterobacter cloacae; Enterobacteriaceae Infections; Half-Life; Imipenem; Kidney Diseases; Male; Meropenem; Penicillinase; Pneumonia, Bacterial; Protein Binding; Rats; Rats, Wistar; Thienamycins; Uranyl Nitrate | 2000 |
Steady-state pharmacokinetics of intramuscular imipenem-cilastatin in elderly patients with various degrees of renal function.
Topics: Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Half-Life; Humans; Imipenem; Injections, Intramuscular; Kidney Diseases | 1991 |
Evaluation of an imipenem/cilastatin target drug program.
Topics: Adult; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Central Nervous System Diseases; Cilastatin; Cilastatin, Imipenem Drug Combination; Cost Savings; Drug Combinations; Drug Costs; Drug Monitoring; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Kidney Diseases; Pharmacy Service, Hospital | 1991 |
[Outline of imipenem/cilastatin sodium].
Topics: Abnormalities, Drug-Induced; Animals; Bacteria; Cilastatin; Cyclopropanes; Drug Combinations; Female; Imipenem; Kidney Diseases; Male; Mice; Pregnancy; Rats; Thienamycins | 1986 |
[Effects of cilastatin sodium, an inhibitor of dehydropeptidase-I, on human urinary peptide excretion. Patients with renal insufficiency].
Topics: Aged; Amino Acids; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Humans; Imipenem; Kidney Diseases; Middle Aged; Peptides; Thienamycins | 1987 |
Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
Topics: Cilastatin; Cyclopropanes; Drug Combinations; Humans; Imipenem; Kidney; Kidney Diseases; Kinetics; Metabolic Clearance Rate; Renal Dialysis; Thienamycins | 1985 |
Imipenem/cilastatin for the treatment of infections in hospitalized children.
Topics: Arthritis, Infectious; Bacterial Infections; Cellulitis; Child; Child, Preschool; Cilastatin; Cyclopropanes; Dipeptidases; Drug Combinations; Escherichia coli Infections; Female; Haemophilus Infections; Hospitalization; Humans; Imipenem; Infant; Kidney Diseases; Lymphadenitis; Male; Prospective Studies; Pseudomonas Infections; Staphylococcal Infections; Streptococcal Infections; Thienamycins; Wound Infection | 1985 |